C. Albor

发表

Both cladribine and alemtuzumab may effect MS via B-cell depletion

K. Schmierer, David Baker, Samuel S. Herrod, 2017, Neurology: Neuroimmunology & Neuroinflammation.

Ethnicity and prevalence of multiple sclerosis in east London

K. Schmierer, B. Turner, K. Boomla, 2017, Multiple sclerosis.

Are poor people healthier in rich or poor areas? : the psychosocial effects of socioeconomic incongruity in the neighbourhood

C. Albor, 2011 .

Impact of ethnic density on adult mental disorders: narrative review

K. Atkin, J. Nazroo, K. Kiernan, 2012, British Journal of Psychiatry.

Positive impact of cladribine on quality of life in people with relapsing multiple sclerosis

K. Schmierer, D. Altmann, D. Baker, 2017, Multiple sclerosis.

The effects of socioeconomic incongruity in the neighbourhood on social support, self-esteem and mental health in England.

D. Ballas, R. Wilkinson, K. Pickett, 2014, Social science & medicine.

Ethnic density effects on physical morbidity, mortality, and health behaviors: a systematic review of the literature.

K. Atkin, J. Nazroo, K. Kiernan, 2012, American journal of public health.

Can We Improve the Monitoring of People With Multiple Sclerosis Using Simple Tools, Data Sharing, and Patient Engagement?

K. Schmierer, A. Stennett, R. Middleton, 2020, Frontiers in Neurology.

EthnicDensityEffectsonPhysicalMorbidity,Mortality,and HealthBehaviors:ASystematicReviewoftheLiterature

K. Atkin, J. Nazroo, K. Kiernan, 2012 .

Cladribine: Off-label disease modification for people with multiple sclerosis in resource-poor settings?

K. Schmierer, G. Giovannoni, D. Soon, 2018, Multiple sclerosis journal - experimental, translational and clinical.

Examining the differential association between self-rated health and area deprivation among white British and ethnic minority people in England.

J. Nazroo, L. Bécares, T. Chandola, 2012, Social science & medicine.